The RADAR-AD (Remote Assessment of Disease and Relapse – Alzheimer’s Disease) project is proud to announce the official launch of its website https://www.radar-ad.org/. RADAR-AD aims to radically improve the assessment of Alzheimer’s disease (AD) and the care for people with AD, by exploring how mobile technologies, such as smart phones, wearables and home-based sensors, can be used to measure disability progression associated with AD. This project receives funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 806999. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
